⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL359725 | 1.00 | — | — | |
| SCHEMBL6130496 | 0.74 | — | — | |
| SCHEMBL3652698 | 0.70 | — | — | |
| SCHEMBL29091056 | 0.70 | — | — | |
| SCHEMBL3652697 | 0.70 | — | — | |
| SCHEMBL6202651 | 0.67 | — | — | |
| SCHEMBL7723498 | 0.67 | — | — | |
| SCHEMBL7723500 | 0.67 | — | — | |
| SCHEMBL10448568 | 0.67 | — | — | |
| SCHEMBL16027140 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12012399-B2 | Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2024-06-18 | — | — | US | disclosed |
| EP-3929197-B1 | INTERMEDIATES FOR THE SYNTHESIS OF MICROBIOCIDAL HETEROBICYCLIC DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2024-03-06 | — | — | EP | disclosed |
| US-11918586-B2 | Treatment of skin lesions | TORQUR AG (CH) | 2024-03-05 | — | — | US | disclosed |
| US-11878972-B2 | Treatment of neurological disorders | TORQUR AG (CH) | 2024-01-23 | — | — | US | disclosed |
| CN-111303116-B | Microbiocidal heterobicyclic derivatives | 先正达参股股份有限公司 | 2023-10-10 | — | — | CN | disclosed |
| US-11744246-B2 | Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide | SYNGENTA PARTICIPATIONS AG (CH) | 2023-09-05 | — | — | US | disclosed |
| EP-3334736-B1 | MICROBIOCIDAL HETEROBICYCLIC DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2023-06-28 | — | — | EP | disclosed |
| CN-109475560-B | Treatment of neurological disorders | 巴塞尔大学 | 2023-05-02 | — | — | CN | disclosed |
| CN-109414415-B | Treatment of skin lesions | 拓客股份有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-110446698-B | Microbicidal quinoline (thio) carboxamide derivatives | 先正达参股股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| EP-1049680-A1 | SUBSTITUTED AMINOALKYLIDENAMINO TRIAZINES AS HERBICIDES | Bayer Aktiengesellschaft (DE) | 2000-11-08 | — | — | EP | disclosed |
| EP-1037882-A1 | SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINES | BAYER AG (DE) | 2000-09-27 | — | — | EP | disclosed |
| EP-1000060-A1 | NOVEL COMPOUNDS | AstraZeneca UK Limited (GB) | 2000-05-17 | — | — | EP | disclosed |
| WO-2000021938-A1 | SUBSTITUTED HERBICIDAL FORMYLAMINOTRIAZINES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-04-20 | — | — | WO | disclosed |
| WO-1999037627-A1 | SUBSTITUTED AMINOALKYLIDENAMINO TRIAZINES AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-07-29 | — | — | WO | disclosed |
| WO-1999029677-A1 | SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-06-17 | — | — | WO | disclosed |
| WO-1999019309-A1 | SUBSTITUTED 2,4-DIAMINO-1,3,5-TRIAZINES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-04-22 | — | — | WO | disclosed |
| WO-1999002528-A1 | NOVEL COMPOUNDS | ASTRA PHARMACEUTICALS LTD. (GB) | 1999-01-21 | — | — | WO | disclosed |
| US-4358591-A | BACTERICIDES, FUNGICIDES; PLANT DISEASES | ZOECON CORPORATION (US) | 1982-11-09 | — | — | US | disclosed |
| US-4307098-A | 2-PHENYL-URACIL COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-12-22 | — | — | US | disclosed |